Targeted Photodynamic Therapy for Drug-Resistant Pulmonary Tuberculosis through Mycolic Acid and Cyclohexadiene-Aminophenyl Interactions.

Targeted Photodynamic Therapy for Drug-Resistant Pulmonary Tuberculosis through Mycolic Acid and Cyclohexadiene-Aminophenyl Interactions.

Publication date: Feb 03, 2025

Open Access PDF

Concepts Keywords
Cyclohexadiene Acid
Photodynamic Aminophenyl
Pulmonary Chem
Therapy Curr
Tuberculosis Cyclohexadiene
Drug
Interactions
Med
Mycolic
Photodynamic
Pulmonary
Resistant
Targeted
Therapy
Tuberculosis

Semantics

Type Source Name
disease MESH Pulmonary Tuberculosis
disease MESH tuberculosis
pathway KEGG Tuberculosis
drug DRUGBANK Medical air
disease MESH latent infections
disease IDO immunodeficiency
drug DRUGBANK Isoniazid
drug DRUGBANK Pyrazinamide
drug DRUGBANK Rifampicin
drug DRUGBANK Streptomycin
drug DRUGBANK Ethambutol
drug DRUGBANK Azelaic acid
drug DRUGBANK Kanamycin
drug DRUGBANK Terizidone
drug DRUGBANK Bedaquiline
drug DRUGBANK Delamanid
drug DRUGBANK Cycloserine
drug DRUGBANK Protionamide
drug DRUGBANK Clarithromycin
disease IDO intervention
disease MESH morbidity
disease MESH lung cancers
disease MESH infections
drug DRUGBANK Oxygen
disease IDO production
drug DRUGBANK Hydrogen peroxide
disease MESH death
drug DRUGBANK BCG vaccine
drug DRUGBANK Phenol
drug DRUGBANK Water
drug DRUGBANK Coenzyme M
drug DRUGBANK Chloride ion
drug DRUGBANK Ethanol
disease IDO process
disease IDO reagent
disease IDO bacteria
disease MESH aids
drug DRUGBANK Phenylpropanolamine
drug DRUGBANK Podofilox
disease IDO assay
drug DRUGBANK Amber
disease IDO site

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *